By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoVista Innovative Therapies, Inc. 

14785 Omicron Drive
Suite 104
San Antonio  Texas  78245  U.S.A.
Phone: 210-677-6000 Fax: 210-677-6001


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
FDA Approves OncoVista Innovative Therapies, Inc.'s Phase I Clinical Trial of New Drug Candidate (OVI-117) for Solid Tumors 7/10/2012 8:31:23 AM
OncoVista Innovative Therapies, Inc. Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patients With Refractory TdT Positive Leukemia 11/29/2011 7:49:15 AM
OncoVista Innovative Therapies, Inc. Initiates Additional Safety Study of OVI-117 7/13/2011 9:01:59 AM
OncoVista Innovative Therapies, Inc. Sells AdnaGen Subsidiary: Total Sale Price Could Reach $65 Million Over Three Years When Milestones Achieved 11/11/2010 8:13:28 AM
OncoVista Innovative Therapies, Inc. Subsidiary Grants Option to License Proprietary Antibodies to KellBenx Inc. 6/18/2010 11:16:50 AM
OncoVista Innovative Therapies, Inc. Updates with Comprehensive Shareholder Letter 6/15/2010 9:24:20 AM
OncoVista Innovative Therapies, Inc. Reports Sharply Higher Q1 Revenues 5/17/2010 2:40:50 PM
OncoVista Innovative Therapies, Inc. Subsidiary AdnaGen Inks Exclusive Agreement with TATAA Molecular Diagnostics 1/26/2010 9:31:13 AM
OncoVista Innovative Therapies, Inc. Reinstated on the OTC Bulletin Board 12/3/2009 2:32:35 PM
OncoVista Innovative Therapies, Inc. Reports on Gene Expression Profiling Study in Circulating Tumor Cells (CTCs) - a Molecular Tool for Therapy Individualization 11/23/2009 9:56:30 AM
1234
//-->